The South Korean government announced that it will start vaccination of medical professionals and others with the new coronavirus developed by British pharmaceutical giant AstraZeneca from the 26th of this month.
However, since it has been pointed out that there is insufficient data on the efficacy of this vaccine for vaccinations over the age of 65, we have decided to inoculate the vaccine under the age of 65 for the time being.
The South Korean government announced at a press conference on the afternoon of the 15th that it will start vaccination with a vaccine developed by British pharmaceutical giant AstraZeneca and others from the 26th of this month.
The target of vaccination is more than 270,000 people under the age of 65, including inpatients in hospitals, residents of medical facilities, and people working in medical facilities.
Regarding the target being under 65 years old, the South Korean government explained that it took into consideration the fact that it was pointed out that there was a lack of efficacy data for vaccinations over 65 years old regarding this vaccine. After collecting more, we will consider how to deal with it.
The South Korean government has signed vaccination contracts with AstraZeneca and Pfizer in the United States, and has secured 56 million people, which exceeds the total population so far.
In the future, the scope of vaccination will be gradually expanded, and by November, more than 70% of the population will be vaccinated, and many people will have immunity, making it difficult for the infection to spread, so-called "herd immunity". It is a policy to aim for the state of.